Risk Reduction (RR) Chapter
The Prevention Research Synthesis (PRS) Project has been conducting on-going systematic reviews (i.e., Risk Reduction (RR) Efficacy Review ) to identify evidence-based interventions (EBIs) that show evidence of efficacy in changing sex or drug-injection behaviors that directly impact HIV-transmission risk. Additional details about the RR Chapter or PRS can be obtained by contacting PRS.
Updated on September 22, 2017
- Starting in December 2016, Risk Reduction interventions focused on non-priority populations and published over 10 years ago will be archived. Please see the Archived Interventions page for further information.
- Beginning in 2015, PRS will focus only on evaluating RR interventions for priority populations, in line with DHAP’s High-Impact Prevention (HIP) approach. More information about upcoming changes to the PRS RR review process.
- Starting October 2014, CDC no longer funds the implementation of the RESPECT intervention after an extensive review of recent evidence and consultation with CDC and external experts.
NEW Risk Reduction Interventions for 2017
- Page last reviewed: September 22, 2017
- Page last updated: September 22, 2017
- Content source: Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention